ClinicalTrials.gg
CompletedNCT07946588Updated Nov 18, 2026

Evaluation of the Reduced Enamel Etching Time Using Universal Adhesives in the Quality of Cervical Lesions Restorations

An interventional study of Enamel Etching time for 5 seconds and Ambar Universal Plus; FGM in Non-Carious Cervical Lesions (NCCLs), sponsored by Universidad de los Andes, Chile. Completed at 1 site in Chile. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Universidad de los Andes, Chile · Not applicable, Interventional, and Treatment

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The aim of this study will be to evaluate the effect of reduced enamel etching time on the 6, 12, 18 and 24-months clinical performance of two universal adhesive systems used as etch-and-rinse application mode in non-carious cervical lesions (NCCLs).

Materials \& Methods: 140 restorations will be randomly placed in 35 subjects according to the following groups: AUP5 (Ambar Universal APS Plus adhesive on enamel etched for 5 seconds); AUP15 (Ambar Universal APS Plus adhesive on enamel etched for 15 seconds); SUB5 (Solare Universal Bond adhesive on enamel etched for 5 seconds); SUB15 (Solare Universal Bond adhesive on enamel etched for 15 seconds). All groups will be light-cured for 10s/1,000 mW/cm2. A resin composite will be placed by applying three increments and each one will be light cured for 20s/1,000 mW/cm2. The restorations will be finished immediately with fine diamond burs and polishers. The restorations will be evaluated at baseline and after 6, 12, 18 and 24-months by using the FDI criteria. The following outcomes will be evaluated: retention, marginal staining, marginal adaptation, post-operative sensitivity and recurrence of caries. The differences among the groups will be calculated using Friedman repeated measures analysis of variance rank (α = 0.05).

Read the detailed description

This is a four-arm, double-blind, randomized controlled clinical trial. Experimental group 1: 35 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Ambar Universal APS Plus; FGM) on enamel etched for 5 seconds in the selective enamel etching application strategy. Experimental group 2: 35 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Solare Bond Universal; GC) on enamel etched for 5 seconds in the selective enamel etching application strategy. Control group 1: 35 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Ambar Universal APS Plus; FGM) on enamel etched for 15 seconds in the selective enamel etching application strategy.

Control group 2: 35 non-carious cervical lesions (NCCL) will receive composite resin restorations using an universal adhesive (Solare Bond Universal; GC) on enamel etched for 15 seconds in the etch-and-rinse application strategy.

LCNCs will be randomized to universal adhesive usage and enamel etching time. All groups will be light-cured with a lightcuring device (SmartLite Focus, Dentsply) with a light intensity of 900 mW/cm² for 10 seconds. Operators will restore the cervical area by applying three increments of resin (Elora, FGM, for Ambar Universal APS Plus and G-ænial A'CHORD, GC, for Solare Bond Universal). Each increment will light cure for 20 s at 900 mW/cm2 (SmartLite Focus, Dentsply). Restorations will be finished immediately with fine and extra fine diamond burs and polished with polishing gums.

02

Conditions studied

  • Non-Carious Cervical Lesions (NCCLs)

Keywords

  • Dental bonding
  • Tooth erosion
  • Tooth Wear
  • Adhesive systems
  • Etching Time
03

In context

Tooth Erosion

48 studies on the registry are indexed under Tooth Erosion; 7 are open to participants now.

This study's enrollment of 35 is close to the median of 34 across 34 interventional studies indexed under Tooth Erosion.

Browse Tooth Erosion studies →

Lead sponsor

Universidad de los Andes, Chile is the lead sponsor of 47 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients older than 18 years.
  • Presence of at least two Non-Carious Cervical Lesions in the dental arch with a need for restorative treatment.
  • Acceptable level of oral hygiene according to the Simplified Oral Hygiene Index.
  • At least 20 teeth in function.
  • Non-Carious Cervical Lesions with a maximum of 50% of enamel margin.

Exclusion criteria

Exclusion Criteria:

  • Driving difficulties that prevent adequate oral hygiene.
  • Periodontal disease.
  • Active caries lesions on the teeth included in the research.
  • Parafunctional habits.
  • Active staples of removable partial dentures on the teeth included in the research and that these are not pillars of prostheses.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Experimental group 1

    35 non-carious cervical lesions (NCCL) will receive composite resin restorations in the selective enamel etch application strategy

    Procedure: Enamel Etching time for 5 seconds · Device: Ambar Universal Plus; FGM

  • Experimental
    Experimental group 2

    35 non-carious cervical lesions (NCCL) will receive composite resin restorations in the selective enamel etch application strategy

    Procedure: Enamel Etching time for 5 seconds · Device: Solare Bond Universal; GC

  • Active comparator
    Control group 1

    35 non-carious cervical lesions (NCCL) will receive composite resin restorations in the selective enamel etch application strategy

    Device: Ambar Universal Plus; FGM · Procedure: Enamel Etching time for 15 seconds

  • Active comparator
    Control group 2

    35 non-carious cervical lesions (NCCL) will receive composite resin restorations in the selective enamel etch application strategy

    Procedure: Enamel Etching time for 15 seconds · Device: Solare Bond Universal; GC

Interventions

  • ProcedureEnamel Etching time for 5 seconds

    Composite resin restorations of non-carious cervical lesions will be performed with an adhesive on enamel etched for 5 seconds in the selective enamel etching application strategy.

  • DeviceAmbar Universal Plus; FGM

    Composite resin restorations of non-carious cervical lesions will be performed with an universal adhesive (Ambar Universal Plus; FGM).

  • ProcedureEnamel Etching time for 15 seconds

    Composite resin restorations of non-carious cervical lesions will be performed with an adhesive on enamel etched for 15 seconds in the selective enamel etching application strategy.

  • DeviceSolare Bond Universal; GC

    Composite resin restorations of non-carious cervical lesions will be performed with an universal adhesive (Solare Bond Universal; GC).

06

What researchers measure

Primary outcomes

  1. Retention of restorations

    Retention measured by World Dental Federation (FDI) criteria as following: * VG: Clinically very good - Restoration retained, no fractures / cracks; * G: Clinically good - Small hairline crack; * SS: Clinically sufficient/satisfactory - Two or more or larger hairline cracks and/or chipping (not affecting the marginal integrity); * US: Clinically unsatisfactory - Chipping fractures which damage marginal quality; bulk fractures with or without partial loss (less than half of the restoration); * PO: Clinically poor - (Partial or complete) loss of restoration, (replacement necessary).

    Time frame: From date of randomization until twenty four months

Secondary outcomes

  1. Marginal Adaptation of restorations

    Marginal Adaptation measured by World Dental Federation (FDI) criteria as following: * VG: Clinically very good - Harmonious outline, no gaps, no discoloration; * G: Clinically good - Small marginal fracture removable by polishing; * SS: Clinically sufficient/satisfactory - Several small enamel or dentin fractures; * US: Clinically unsatisfactory - Notable enamel or dentine wall fracture; * PO: Clinically poor - Filling is loose but in situ.

    Time frame: From date of randomization until twenty four months

  2. Marginal Staining of restorations

    Marginal Staining measured by World Dental Federation (FDI) criteria as following: * VG: Clinically very good - No marginal staining; * G: Clinically good - Minor marginal staining, easily removable by polishing; * SS: Clinically sufficient/satisfactory - Moderate marginal staining, not esthetically unacceptable; * US: Clinically unsatisfactory - Pronounced marginal staining; major intervention necessary for improvement; * PO: Clinically poor - Deep marginal staining not accessible for intervention

    Time frame: From date of randomization until twenty four months

07

Study locations

1 site
  • Mario Felipe Gutiérrez Reyes
    Santiago, Santiago Metropolitan 8360053, Chile
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2026 to primary completion in Sep 2026, 0 months.

Of 21 interventional studies with no phase under Tooth Erosion, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 28. This study's 0 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 18, 2026
StartActual
Sep 15, 2026
Primary completionActual
Sep 29, 2026
CompletionActual
Sep 29, 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07946588
Lead sponsor
Universidad de los Andes, Chile
Collaborators
Agencia Nacional de Investigación y Desarrollo
Responsible party
Mario Felipe Gutiérrez Reyes (Associate Professor, Universidad de los Andes, Chile) — Principal investigator
First posted
Nov 18, 2026
Start date
Sep 15, 2026
Primary completion
Sep 29, 2026
Completion
Sep 29, 2026
Last update
Nov 18, 2026

Study contacts

Mario Felipe Gutiérrez Reyes, PhD
study director · Universidad de los Andes, Chile

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion